Peer To Peer Education

Don't Just Take It From Us...

Explore the firsthand accounts below and learn more from the very people who are prescribing the long-term Eversense CGM system and changing lives 90 days at a time. Learn about the benefits that Eversense can bring to your practice and how it can positively impact your patients' health and well-being.

MEET DR. AMIR HARARI

Hear firsthand why award-winning endocrinologist, Dr. Harari is sharing Eversense with his patients.

JOANNE ARNOLD, NP

Listen to nurse practitioner, Joanne Arnold explain the advantages of the Eversense CGM system.

The providers in these videos have been sponsored by Senseonics to appear in the videos. The opinions expressed belong solely to the provider. This information provides general information only. It is not intended to be used as medical advice, diagnosis or treatment and should not replace the advice of a Health Care Provider. A Health Care Provider must be consulted and the device user manual reviewed in full before use. Individual results may vary, testimonials are not claimed to represent typical results. All testimonials are not intended to represent or guarantee that anyone will achieve the same or similar results.

*Patients should check with their insurance company for a complete description of plan benefits, exclusions, limitations and conditions of coverage. Insurance plan features and availability may vary by service area.

 

You’re getting good reimbursement on Eversense. This is better than any other sensor out there and it is very good for our practice. It’s well worthwhile from a management and business standpoint.

DR. BRUCE BODE / ATLANTA, GEORGIA

Ready to Get Started
as a Provider?

GET STARTED
 

Disclaimer

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information click here.

Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.